Skip to content
-
Subscribe to our newsletter & never miss our best posts. Subscribe Now!
Today's News. Tomorrow's Perspective. Today's News. Tomorrow's Perspective.

Deliver fast, factual, and easy-to-understand news covering global events, technology, business, science, AI, health, entertainment, and lifestyle.

Today's News. Tomorrow's Perspective. Today's News. Tomorrow's Perspective.

Deliver fast, factual, and easy-to-understand news covering global events, technology, business, science, AI, health, entertainment, and lifestyle.

  • Home
  • Breaking News
  • Business
  • Sports
  • Health
  • Politics
  • Technology & AI
  • World
  • Home
  • Breaking News
  • Business
  • Sports
  • Health
  • Politics
  • Technology & AI
  • World
Close

Search

Subscribe
Three questions about the latest study on statin deprescribing
Health

Three questions about the latest study on statin deprescribing

Stephen Atcheler
By Stephen Atcheler
November 19, 2026 2 Min Read
Comments Off on Three questions about the latest study on statin deprescribing

At the recent American Heart Association annual meeting, the main theme dominating the stage, bathed in Pantone red, was one of the most high-profile neutral discoveries.

Listening to the results of the STREAM trial — which found that older people without a history of heart attack or stroke who stopped taking statins did not have significantly different outcomes than those who continued taking them — I noted that the study continued the theme.

But as the Kaplan-Meier curves were projected onto the screen, something was wrong: the curves were diverging instead of staying together. Theoretically, this scenario can occur in non-inferiority studies, in which researchers test whether an intervention offers similar results compared to a standard. Statin deprescription in this group, according to the expectations set by researchers at the start of STREAM, was technically noninferior, but nonetheless inferior. Patients randomized to stop taking their statin had worse outcomes than those who continued. Even the trial’s data safety monitoring board suggested that patients who have stopped taking statins should talk to their doctors about restarting their treatment.

Exclusive STAT+ story

Already have an account? Log in

STAT+

STAT+

This article is reserved for STAT+ subscribers

Unlock this article, plus in-depth analysis, newsletters, premium events and news alerts.

Already have an account? Log in

See all packages

To read the rest of this story, subscribe to STAT+.

Subscribe

Gn Health

Views: 4
Stephen Atcheler
Author

Stephen Atcheler

**Stephen** is a staff journalist at **DailyVoxa**, specializing in business, finance, technology, artificial intelligence, and global markets. He is committed to delivering timely, accurate, and insightful reporting that helps readers understand the forces shaping the global economy and the rapidly evolving digital landscape.Drawing on in-depth research and credible sources, Stephen covers breaking developments, industry trends, and emerging innovations with a focus on clarity, balance, and factual accuracy. His reporting is designed to provide readers with reliable information, practical context, and thoughtful analysis without sensationalism.As a member of the DailyVoxa editorial team, Stephen follows the publication's Editorial Policy, Fact-Checking Policy, Corrections Policy, and Ethics Policy. Every article is carefully reviewed to ensure it meets the highest standards of journalistic integrity, transparency, and editorial independence.

Follow Me
Other Articles
NFL QB Rankings, Week 11: Kirk Cousins ​​rises; Josh Allen slips out of top three | Latest NFL News, Analysis and Updates
Previous

NFL QB Rankings, Week 11: Kirk Cousins ​​rises; Josh Allen slips out of top three | Latest NFL News, Analysis and Updates

Trump, Xi and Putin sit down for rare three-way meeting in China
Next

Trump, Xi and Putin sit down for rare three-way meeting in China

Deliver fast, factual, and easy-to-understand news covering global events, technology, business, science, AI, health, entertainment, and lifestyle.
  • About Us
  • Accessibility Statement
  • Advertise With Us
  • AI Usage & Transparency Policy
  • Contact us
  • Cookie Policy
  • Corrections Policy
  • Meet Our Team
  • Privacy Policy
    • Disclaimer
    • DMCA & Copyright Policy
    • Editorial Policy
    • Ethics Policy
    • Fact-Checking Policy
  • Terms and Conditions
Copyright 2026 — Today's News. Tomorrow's Perspective.. All rights reserved.